Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.88B P/E - EPS this Y 10.70% Ern Qtrly Grth -
Income -615.06M Forward P/E -2.87 EPS next Y 2.90% 50D Avg Chg -38.00%
Sales 86.18M PEG -0.28 EPS past 5Y - 200D Avg Chg -43.00%
Dividend N/A Price/Book 0.95 EPS next 5Y 7.00% 52W High Chg -55.00%
Recommedations 2.20 Quick Ratio 8.75 Shares Outstanding 135.03M 52W Low Chg 12.00%
Insider Own 14.23% ROA -17.48% Shares Float 88.97M Beta 0.41
Inst Own 76.29% ROE -33.54% Shares Shorted/Prior 4.96M/5.08M Price 14.04
Gross Margin - Profit Margin - Avg. Volume 1,171,953 Target Price 32.29
Oper. Margin -724.57% Earnings Date May 2 Volume 673,389 Change -1.40%
About Vir Biotechnology, Inc.

Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It offers tobevibart + elebsiran for the treatment of chronic hepatitis delta; elebsiran + PEG-IFN-a, tobevibart ± elebsiran ± PEG-IFN-a, and elebsiran+ TLR8+PD-1 for the treatment of chronic hepatitis B; VIR-1388 and Cure mAb combination for the treatment of human immunodeficiency virus; VIR-8190 for the treatment of respiratory syncytial virus / human metapneumovirus; VIR-2981 for the treatment of influenza; VIR-1949 for the treatment of pre-cancerous HPV lesions; and VIR07229 and Sotrovimab for the treatment of COVID-19 infection under the Xevudy brand. The company has grant agreements with Bill & Melinda Gates Foundation and National Institutes of Health; an option and license agreement with Brii Biosciences Limited; a collaboration and license agreement with Alnylam Pharmaceuticals, Inc.; license agreements with MedImmune; collaboration with WuXi Biologics and Glaxo Wellcome UK Ltd.; and a collaborative research agreement with GlaxoSmithKline Biologicals SA. It also has a manufacturing agreement with Samsung Biologics Co.,Ltd. for the manufacture of SARS-COV-2 antibodies. The company was incorporated in 2016 and is headquartered in San Francisco, California.

Vir Biotechnology, Inc. News
04/18/24 Vir Biotechnology Announces Nomination of Norbert Bischofberger, Ph.D. and Ramy Farid, Ph.D. to its Board of Directors
04/11/24 Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024
04/04/24 Vir Biotechnology Inc CEO Backer De Sells 72,995 Shares
03/19/24 From Six Figures to Seven: 3 Biotech Stocks Set to Make Millionaires
03/13/24 Billionaire’s Biotech Bets: 3 Stocks Dominating Bill Gates’ Portfolio
03/05/24 Vir Biotechnology Completes Enrollment of Phase 2 Chronic Hepatitis Delta SOLSTICE Trial Ahead of Schedule
02/23/24 Q4 2023 Vir Biotechnology Inc Earnings Call
02/23/24 Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript
02/23/24 Wall Street Analysts Believe Vir Biotechnology, Inc. (VIR) Could Rally 186.41%: Here's is How to Trade
02/23/24 Vir Biotechnology to Participate in Upcoming Investor Healthcare Conferences
02/22/24 Vir Biotechnology, Inc. (VIR) Reports Q4 Loss, Tops Revenue Estimates
02/22/24 Vir Biotechnology Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
04:30 PM Vir Biotechnology Announces Dr. Phil Pang Will Step Down as Chief Medical Officer
02/14/24 3 Hidden-Gem Biotech Stocks Ready to Ride a Massive Market Wave
02/07/24 Vir Biotechnology, Inc. (NASDAQ:VIR) Analysts Just Trimmed Their Revenue Forecasts By 11%
02/01/24 Vir Biotechnology to Provide Business Update and Report Fourth Quarter 2023 Financial Results on February 22, 2024
01/03/24 Regeneron (REGN) Surges 3.0%: Is This an Indication of Further Gains?
12/13/23 Vir Biotechnology Announces Strategic Steps to Reduce Operating Expenses and Focus Investment on Areas with Highest Potential for Value Creation
12/06/23 Vir Biotechnology to Present at J.P. Morgan 2024 42nd Annual Healthcare Conference
11/30/23 7 Small-Cap Stocks to Buy BEFORE the Year-End Rally
VIR Chatroom

User Image Dunnieboy1 Posted - 20 hours ago

$VIR if you check your email addresses there should be voting forms for the upcoming agm, just general stuff like reappointing the CEO & new directors etc.

User Image Ecnerual Posted - 22 hours ago

$VIR Interesting article about $VIR CEO Marianne de Backer came out today. She has an enormous bonus package, so hopefully this year $VIR will deliver. https://www.fiercebiotech.com/biotech/how-vir-found-one-ceo-marianne-de-backer

User Image Ecnerual Posted - 2 days ago

$VIR Two new members for the Board of Directors at $VIR, with lots of experience in bringing drugs to market. Hopefully $VIR will bring one of their drug candidates to market via FDA fast track this year! https://investors.vir.bio/news/news-details/2024/Vir-Biotechnology-Announces-Nomination-of-Norbert-Bischofberger-Ph.D.-and-Ramy-Farid-Ph.D.-to-its-Board-of-Directors/default.aspx

User Image deezstocks3 Posted - 3 days ago

$VIR Up 7% after hours 🤔

User Image Dunnieboy1 Posted - 3 days ago

$VIR mkt cap $1.16bn, cash & investments $1.7bn, means nothing if we dont produce the goods but if we do🚀.

User Image tock_strader Posted - 4 days ago

$VIR looks like we will have a chance to scoop some in the sevens

User Image Dunnieboy1 Posted - 4 days ago

$VIR brutal times in the market.

User Image tock_strader Posted - 5 days ago

$VIR This is a s***** price to be stuck at

User Image Jhawkin Posted - 1 week ago

$VIR GTFO Marianne De Backer! Selling 80,000 shares isn’t for taxes. You’re cashing in on your grift. Thanks for the ZERO confidence you have in the company you “lead”. Probably a BCG plant. No positive price movement since you were installed as CEO. Not a single purchase, now dumping 11% of your position that you didn’t put a penny of your own money into. Now that the SVF cancer has paused constant selling, our overpaid execs step up to take over the downward death spiral with the continued sell off. I’m not leaving because I believe in the great team of scientists & researchers on our team, with a promising pipeline. I’ll think twice about ever investing in any company where the insiders don’t have an ounce of skin in the game and just shit on the shareholders from their gold-lined bidet.

User Image Ecnerual Posted - 1 week ago

$VIR No… not below 9 again. Time to buy the dip I guess….

User Image Stock_Titan Posted - 1 week ago

$VIR Vir Biotechnology to Provide Business Update and Report First Quarter 2024 Financial Results on May 2, 2024 https://www.stocktitan.net/news/VIR/vir-biotechnology-to-provide-business-update-and-report-first-wzt6o57tu9qd.html

User Image Dunnieboy1 Posted - 1 week ago

$VIR Alpine on the back of this deal was up 20% in normal hours and a further 36% in post market trading.

User Image Dunnieboy1 Posted - 1 week ago

$VIR i honestly don’t want us sold until we have taken our pipeline has progressed and we have drugs approved, then we may not sell or need to sell but the mergers & acquisi tions are certainly making biotech the hot sector, here’s the latest one. Vertex strikes $4.9B deal for Alpine, expanding work in kidney and autoimmune diseases.

User Image Dunnieboy1 Posted - 1 week ago

$VIR trading like Bitcoin the last few days,😂

User Image Dunnieboy1 Posted - 1 week ago

$VIR Wtf, up 4.21% and now back down,shorters battering us down? Well one day the shorters have to buy to close their positions.

User Image Mhand Posted - 1 week ago

$VIR Every time we go up 5% or more.

User Image Dunnieboy1 Posted - 1 week ago

$VIR nice up 4.21%

User Image StockInvest_us Posted - 1 week ago

Signal alert: $VIR - Oversold Trend Short (Undervalued) https://stockinvest.us/l/Z34Ze1EaEh

User Image Dunnieboy1 Posted - 1 week ago

$VIR as the previous post states trial concludes this month, might be some big news soon Vir & Alnylam have been working on this for 3/4 years so you would think the trials would be positive.

User Image fda_tracker Posted - 1 week ago

$VIR Phase 2 trial w/est Apr completion date NCT04412863: https://www.clinicaltrials.gov/study/NCT04412863 Trial Tracker: https://www.fdatracker.com/trial-tracker/

User Image Dunnieboy1 Posted - 2 weeks ago

$VIR i’m still a believer.

User Image insiderbuyingselling Posted - 2 weeks ago

$VIR new insider selling: 72995 shares. http://insiderbuyingselling.com/?t=VIR

User Image deezstocks3 Posted - 2 weeks ago

$VIR looks like our old CMO, Phillip Pang, just exercised 53,000 shares. Ugh

User Image tock_strader Posted - 2 weeks ago

$VIR I am back in. First time in 2 years. Pretty low conviction, not going to lie.

User Image MandoTA Posted - 2 weeks ago

Same old $VIR

User Image rispi Posted - 2 weeks ago

$VIR two and a half years cash on hand is there any plausible catalyst on that way?

User Image insiderbuyingselling Posted - 2 weeks ago

$VIR new insider selling: 2711 shares. http://insiderbuyingselling.com/?t=VIR

User Image Dunnieboy1 Posted - 2 weeks ago

$VIR after hours this will be 3-4% up

User Image Dunnieboy1 Posted - 2 weeks ago

$VIR i honestly never believed we’d hit this level again, well i’m digging in & buying but maybe i’m just stupidly stubborn or are they ’shaking the tree’?

User Image Jhawkin Posted - 2 weeks ago

$VIR cash on hand = $11.72/share…just cash alone, not combined assets and/or bullish pipeline. Who the hell is selling at these ridiculous prices? Even crooked hedge funds & institutions aren’t that dumb. So who’s manipulating this down and why? 🤔

Analyst Ratings
HC Wainwright & Co. Buy Mar 15, 24
JP Morgan Neutral Feb 23, 24
HC Wainwright & Co. Buy Feb 14, 24
JP Morgan Neutral Jan 29, 24
HC Wainwright & Co. Buy Jan 23, 24
Needham Buy Nov 3, 23
B of A Securities Neutral Sep 8, 23
HC Wainwright & Co. Buy Aug 7, 23
Needham Buy Aug 4, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Pang Phillip EVP & Chief Medical.. EVP & Chief Medical Officer Jan 02 Option 1.32 80,000 105,600 268,000 01/03/24
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Jun 30 Sell 25.11 700 17,577 16,684,041 07/05/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Jun 28 Sell 25.14 96,952 2,437,373 16,684,741 06/30/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Jun 20 Sell 25.1769 9,902 249,302 16,781,693 06/22/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Jun 15 Sell 25.83 183,326 4,735,311 16,791,595 06/20/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Jun 13 Sell 26.55 164,102 4,356,908 16,974,921 06/15/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Jun 02 Sell 27.32 39,562 1,080,834 17,139,023 06/06/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner May 23 Sell 26.45 274,451 7,259,229 17,178,585 05/25/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner May 19 Sell 25.55 183,547 4,689,626 17,453,036 05/23/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner May 05 Sell 25.1032 136 3,414 17,636,583 05/09/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner May 03 Sell 25.53 198,006 5,055,093 17,636,719 05/05/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner May 01 Sell 25.3047 3,075 77,812 17,834,725 05/03/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Apr 24 Sell 25.36 66,999 1,699,095 17,837,800 04/26/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Apr 20 Sell 25.61 311,983 7,989,885 17,904,799 04/24/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Apr 18 Sell 25.12 83,067 2,086,643 18,216,782 04/20/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Apr 14 Sell 25.08 20,089 503,832 18,299,849 04/18/23
Friedl-Naderer Johanna EVP & Chief Operatin.. EVP & Chief Operating Officer Mar 03 Sell 22.82 1,482 33,819 148,518 03/07/23
Pang Phillip Chief Medical Office.. Chief Medical Officer Feb 22 Sell 25.97 2,878 74,742 198,320 02/24/23
Rice Steven J. Chief Administrative.. Chief Administrative Officer Feb 22 Sell 25.97 1,795 46,616 108,414 02/24/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Feb 21 Sell 28.01 74,477 2,086,101 18,319,938 02/23/23
SCANGOS GEORGE A President and CEO President and CEO Feb 17 Sell 27.37 27,750 759,518 196,239 02/21/23
Rice Steven J. Chief Administrative.. Chief Administrative Officer Feb 17 Sell 25.288 1,981 50,096 37,209 02/21/23
Pang Phillip Chief Medical Office.. Chief Medical Officer Feb 17 Sell 25.288 2,802 70,857 141,198 02/21/23
Horn Howard CFO CFO Feb 17 Sell 25.288 2,424 61,298 232,960 02/21/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Feb 15 Sell 26.7525 38,964 1,042,384 18,394,415 02/17/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Feb 13 Sell 26.24 117,957 3,095,192 18,433,379 02/15/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Feb 09 Sell 26.32 234,271 6,166,013 18,551,336 02/13/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Feb 07 Sell 28.58 145,422 4,156,161 18,785,607 02/09/23
SATO VICKI L Director Director Feb 08 Sell 28.68 17,915 513,802 1,345,259 02/09/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Feb 03 Sell 30.06 114,035 3,427,892 18,931,029 02/07/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Feb 01 Sell 29.22 148,635 4,343,115 19,045,064 02/03/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Jan 30 Sell 29.48 152,813 4,504,927 19,193,699 02/01/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Jan 23 Sell 28.13 36,512 1,027,083 19,346,512 01/25/23
Pang Phillip Chief Medical Office.. Chief Medical Officer Jan 24 Sell 30 30,000 900,000 144,000 01/25/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Jan 19 Sell 26.73 214,197 5,725,486 19,383,024 01/23/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Jan 17 Sell 26.28 190,839 5,015,249 19,597,221 01/19/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Jan 12 Sell 26.36 211,678 5,579,832 19,788,060 01/17/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Jan 10 Sell 26.19 149,640 3,919,072 19,999,738 01/12/23
SATO VICKI L Director Director Jan 09 Sell 25.8322 17,915 462,784 1,363,174 01/11/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Jan 06 Sell 25.97 100,980 2,622,451 20,149,378 01/10/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Jan 03 Sell 25.52 9,177 234,197 20,250,358 01/05/23
Sigal Charles Elliott Director Director Jan 03 Buy 25.43 5,000 127,150 5,000 01/05/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Dec 29 Sell 25.5487 44,169 1,128,461 20,259,535 01/03/23
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Dec 27 Sell 25.5918 6,850 175,304 20,303,704 12/29/22
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Dec 22 Sell 25.96 175,225 4,548,841 20,310,554 12/27/22
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Dec 20 Sell 25.83 215,756 5,572,977 20,485,779 12/22/22
SATO VICKI L Director Director Dec 08 Sell 25.8089 17,915 462,366 1,381,089 12/09/22
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Dec 02 Sell 27.36 97,293 2,661,936 20,701,535 12/06/22
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Nov 30 Sell 27.82 212,329 5,906,993 20,798,828 12/02/22
SVF Endurance (Cayman) Ltd 10% Owner 10% Owner Nov 28 Sell 27.62 109,115 3,013,756 21,011,157 11/30/22